CN104031902A - Oleaginous yeast ATP citrate lyase (ACL) and application thereof - Google Patents
Oleaginous yeast ATP citrate lyase (ACL) and application thereof Download PDFInfo
- Publication number
- CN104031902A CN104031902A CN201310067821.2A CN201310067821A CN104031902A CN 104031902 A CN104031902 A CN 104031902A CN 201310067821 A CN201310067821 A CN 201310067821A CN 104031902 A CN104031902 A CN 104031902A
- Authority
- CN
- China
- Prior art keywords
- acl
- seq
- nucleotide sequence
- yeast
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 47
- 108090000662 ATP citrate synthases Proteins 0.000 title claims description 40
- 102000004146 ATP citrate synthases Human genes 0.000 title claims description 31
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 64
- 241000221523 Rhodotorula toruloides Species 0.000 claims abstract description 44
- 239000002773 nucleotide Substances 0.000 claims abstract description 27
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 27
- 239000013598 vector Substances 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 241000894006 Bacteria Species 0.000 claims abstract description 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 20
- 230000000694 effects Effects 0.000 claims description 12
- 241000195597 Chlamydomonas reinhardtii Species 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000316848 Rhodococcus <scale insect> Species 0.000 claims description 6
- 241000195585 Chlamydomonas Species 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims description 3
- 241000192707 Synechococcus Species 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 2
- 241001522404 Rhyparus opacus Species 0.000 claims 1
- 230000008034 disappearance Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 230000014509 gene expression Effects 0.000 abstract description 16
- 238000012163 sequencing technique Methods 0.000 abstract description 16
- 108020004414 DNA Proteins 0.000 abstract description 13
- 239000002299 complementary DNA Substances 0.000 abstract description 11
- 238000010276 construction Methods 0.000 abstract description 9
- 238000009825 accumulation Methods 0.000 abstract description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 4
- 241000223252 Rhodotorula Species 0.000 abstract description 4
- 238000003757 reverse transcription PCR Methods 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 30
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- 239000013612 plasmid Substances 0.000 description 24
- 239000002609 medium Substances 0.000 description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 150000002632 lipids Chemical group 0.000 description 9
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 241001524101 Rhodococcus opacus Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 4
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000004520 electroporation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 101150073246 AGL1 gene Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000003225 biodiesel Substances 0.000 description 3
- 239000013599 cloning vector Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 108010036824 Citrate (pro-3S)-lyase Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000119319 Rhodococcus opacus PD630 Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108010028230 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys Proteins 0.000 description 2
- 101150050575 URA3 gene Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- -1 fatty acid esters Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011223 gene expression profiling Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 230000013190 lipid storage Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000590031 Alteromonas Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241001135744 Colwellia Species 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- 102000015303 Fatty Acid Synthases Human genes 0.000 description 1
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 1
- 241000178316 Ferrimonas Species 0.000 description 1
- 101150112014 Gapdh gene Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 1
- 101000718476 Homo sapiens L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase Proteins 0.000 description 1
- 102100026384 L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241000907999 Mortierella alpina Species 0.000 description 1
- 101100364971 Mus musculus Scai gene Proteins 0.000 description 1
- 101150005851 NOS gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000206731 Phaeodactylum Species 0.000 description 1
- 241001542817 Phaffia Species 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 241000519590 Pseudoalteromonas Species 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000653837 Rhodotorula toruloides NP11 Species 0.000 description 1
- 235000005291 Rumex acetosa Nutrition 0.000 description 1
- 240000007001 Rumex acetosella Species 0.000 description 1
- 101100386089 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MET17 gene Proteins 0.000 description 1
- 241000863430 Shewanella Species 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012913 medium supplement Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007058 regulation of lipid biosynthetic process Effects 0.000 description 1
- 230000028503 regulation of lipid metabolic process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 235000003513 sheep sorrel Nutrition 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/03—Oxo-acid-lyases (4.1.3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及ATP柠檬酸裂解酶ACL,具体地说是自圆红冬孢酵母分离的ATP柠檬酸裂解酶基因的克隆、重组载体构建,以及在基因工程研究中的应用。The invention relates to ATP citrate lyase ACL, specifically the cloning of the ATP citrate lyase gene isolated from Rhodosporidium toruloides, the construction of a recombinant vector and its application in genetic engineering research.
背景技术Background technique
国际石油价格屡创新高,低油价的时代一去不复返。为了保障国家石油安全,缓解石油过度依赖进口的危机,同时有效降低机动车污染物排放,我国正大力推动生物柴油的发展。生物柴油主要指以动植物油脂为原料,用甲醇或乙醇在催化剂作用下经脂交换制成的脂肪酸酯。然而利用动植物油脂为原料存在着与人争粮与农争地的问题,而微生物因其生长快、基本不依赖耕地、可连续生产、便于改造等特点,今年来显示出其突出的特点[赵宗保.中国生物工程杂志2005,25(2),8-11]。因此利用微生物生产油脂为生物柴油提供原料是现今可选替代方案之一。International oil prices hit new highs repeatedly, and the era of low oil prices is gone forever. In order to ensure national oil security, ease the crisis of over-reliance on oil imports, and effectively reduce motor vehicle pollutant emissions, my country is vigorously promoting the development of biodiesel. Biodiesel mainly refers to fatty acid esters made from animal and vegetable oils through lipid exchange with methanol or ethanol under the action of a catalyst. However, the use of animal and vegetable oils and fats as raw materials has the problem of competing with people for food and land. Microorganisms have shown their outstanding characteristics this year because of their fast growth, basically independent of arable land, continuous production, and easy transformation.[ Zhao Zongbao. China Biotechnology Journal 2005, 25(2), 8-11]. Therefore, the use of microorganisms to produce oil to provide raw materials for biodiesel is one of the available alternatives today.
自然界中部分微生物在极端情况(如氮源缺乏)能在胞内积累超过其细胞干重20%的油脂,其中以甘油三酯为主,这些微生物被称为产油微生物。主要包括细菌、酵母、霉菌、藻类等。其中产油酵母包括Rhodotorula,Candida,Cryptococcus,Rhizopus,Trichosporon和Yarrowia属中的某些菌株[Ratledge C,Wynn J P.Adv Appl Microbiol2002,51,1-51]。产油细菌包括Colwellia,Shewanella,Alteromonas,Pseudoalteromonas和Ferrimonas属中的某些菌株[相光明.粮食与油脂2008(6),7-11]。产油微藻包括Chlorella,Nannoch l和Phaeodactylums属中的某些菌株[郑洪立,中国生物工程学报2009,29,110-116。王立柱,微生物学通报2010,37,336-347。]Some microorganisms in nature can accumulate oil exceeding 20% of their dry cell weight in the cells under extreme conditions (such as nitrogen source deficiency), mainly triglycerides, and these microorganisms are called oleaginous microorganisms. Mainly including bacteria, yeast, mold, algae and so on. The oleaginous yeasts include some strains in the genera Rhodotorula, Candida, Cryptococcus, Rhizopus, Trichosporon and Yarrowia [Ratledge C, Wynn J P. Adv Appl Microbiol 2002, 51, 1-51]. Oleaginous bacteria include certain strains in the genera Colwellia, Shewanella, Alteromonas, Pseudoalteromonas and Ferrimonas [Xiang Guangming. Grain and Oil 2008(6), 7-11]. Oleaginous microalgae include certain strains in the genera Chlorella, Nannoch l and Phaeodactylums [Zheng Hongli, Chinese Journal of Biotechnology 2009, 29, 110-116. Wang Lizhu, Microbiology Bulletin 2010, 37, 336-347. ]
关于产油酵母,尤其是红酵母基因工程改造的研究相对匮乏,其在特定条件下积累油脂的机制仍未从分子水平上进行阐明仅仅从生化阐明产油酵母在调控油脂合成代谢过程中可能是ATP柠檬酸裂解酶(ACL)和苹果酸脱氢酶(ME)起到关键作用[Evans,C.T.and C.Ratledge.CanadianJournal of Microbiology1985,31:1000-1005.]。ACL存在于细胞质中,催化柠檬酸裂解为乙酰辅酶A和草酰乙酸。它广泛存在于油脂酵母和霉菌中。在非产油酵母(即积累油脂不超过细胞干重20%)中不存在这个酶。近年来,有研究表明,红发夫酵母中ACL基因在限氮条件下,随着氮源的减少活性增大,其活性的提高有助于虾青素的积累[Cipriano Chávez-Cabrera,Zoila R,et al.Appl Microbiol Biotechnol2010,85:1953-1960.]。另有研究表明,在高山被孢霉(Mortierella alpina)中表达来源于自身的ACL基因,能够脂肪酸含量得到较大的提高[专利号:200880113428.X]。The research on oleaginous yeast, especially Rhodotorula, is relatively scarce, and the mechanism of oil accumulation under specific conditions has not been elucidated at the molecular level. It is only biochemically clarified that oleaginous yeast may play a role in the regulation of lipid synthesis and metabolism. ATP citrate lyase (ACL) and malate dehydrogenase (ME) play key roles [Evans, C.T. and C. Ratledge. Canadian Journal of Microbiology 1985, 31:1000-1005.]. ACL exists in the cytoplasm and catalyzes the cleavage of citrate to acetyl-CoA and oxaloacetate. It is widely found in oleaginous yeasts and molds. This enzyme is absent in non-oleaginous yeasts (ie accumulating lipids not exceeding 20% of dry cell weight). In recent years, studies have shown that the activity of the ACL gene in Phaffia rhodozyme increases with the reduction of nitrogen sources under nitrogen-limited conditions, and the increase in its activity contributes to the accumulation of astaxanthin [Cipriano Chávez-Cabrera, Zoila R , et al. Appl Microbiol Biotechnol 2010, 85: 1953-1960.]. Another study showed that the expression of the ACL gene derived from itself in Mortierella alpina can greatly increase the fatty acid content [Patent No.: 200880113428.X].
但是,至今为止未有人进行过产油酵母的ACL基因的分离及其基因功能的鉴定,也没有人使用这个基因进行过油脂的生产。However, so far no one has isolated the ACL gene of oleaginous yeast and identified its gene function, and no one has used this gene for oil production.
发明内容Contents of the invention
本发明的目的是提供一种产油酵母ATP柠檬酸裂解酶蛋白、其编码核苷酸序列以及应用。具体来说,是一种来源于圆红冬孢酵母CGMCC2.1389的ATP柠檬酸裂解酶新基因Rt-ACL的克隆和生物功能分析,以及该基因在构建重组载体和构建基因工程菌株领域的应用。The purpose of the present invention is to provide an oleaginous yeast ATP citrate lyase protein, its coding nucleotide sequence and application. Specifically, it is the cloning and biological function analysis of a new ATP citrate lyase gene Rt-ACL derived from Rhodosporidium toruloides CGMCC2.1389, and the application of this gene in the field of constructing recombinant vectors and constructing genetically engineered strains .
为实验上述目的,本发明采用的技术方案为:For experimenting above-mentioned purpose, the technical scheme that the present invention adopts is:
首先,利用圆红冬孢酵母转录组测序结果,设计cDNA扩增的引物,以圆红冬孢酵母CGMCC2.1389总RNA为模板,经RT-PCR得到ATP柠檬酸裂解酶基因Rt-ACL,其cDNA具有如序列表SEQ ID NO:1所示的序列,其基因组DNA具有如序列表SEQ ID NO:2所示的序列,其氨基酸具有如序列表SEQ ID NO:3所示的序列。而后通过将其导入酿酒酵母(Saccharomyces cerevisiae)中,由于酿酒酵母中不存在ACL基因,因此能够对ACL的活性进行检测[Beth L.Fatland,Jinshan Ke,et al.PlantPhysiology2002,130:740-756.]。最后通过将这个功能确定的基因在红酵母自身、其他产油酵母及其他产油细菌、微藻中进行过表达,获得了油脂含量大量提高的菌株。First, using the results of Rhodosporidium toruloides transcriptome sequencing, primers for cDNA amplification were designed, and the total RNA of Rhodosporidium toruloides CGMCC2.1389 was used as a template to obtain the ATP citrate lyase gene Rt-ACL by RT-PCR. cDNA has the sequence shown in SEQ ID NO: 1 in the sequence table, its genomic DNA has the sequence shown in SEQ ID NO: 2 in the sequence table, and its amino acid has the sequence shown in SEQ ID NO: 3 in the sequence table. Then by introducing it in Saccharomyces cerevisiae, since there is no ACL gene in Saccharomyces cerevisiae, the activity of ACL can be detected [Beth L.Fatland, Jinshan Ke, et al.PlantPhysiology2002, 130:740-756. ]. Finally, by overexpressing the functionally determined gene in Rhodotorula, other oleaginous yeasts, other oleaginous bacteria, and microalgae, a strain with a large increase in oil content was obtained.
本发明提供的产油酵母ATP柠檬酸裂解酶,名称为Rt-ACL(R.toruloides ATP-citrate lyase,圆红冬孢酵母ATP柠檬酸裂解酶),来源于圆红冬孢酵母R.toruloides CGMCC2.1389。所述产油酵母ATP柠檬酸裂解酶是由如下(a)或(b)的蛋白质:The oleaginous yeast ATP citrate lyase provided by the invention is called Rt-ACL (R.toruloides ATP-citrate lyase, Rhodosporidium toruloides ATP citrate lyase), derived from Rhodosporidium toruloides CGMCC2 .1389. The oleaginous yeast ATP citrate lyase is composed of the following (a) or (b) protein:
(a)由SEQ ID NO:3所示的氨基酸序列组成的蛋白质;(a) a protein consisting of the amino acid sequence shown in SEQ ID NO: 3;
(b)将SEQ ID NO:3的氨基酸经过一个或几个氨基酸的取代和/或缺失和/或添加且与具有油脂贮运和代谢调控相关活性的由SEQ ID NO:3衍生的蛋白质。(b) The amino acid of SEQ ID NO: 3 undergoes one or several amino acid substitutions and/or deletions and/or additions, and is related to a protein derived from SEQ ID NO: 3 with activities related to lipid storage and transportation and metabolic regulation.
为了使(a)中的蛋白便于纯化,可以由SEQ ID NO:3所示的氨基酸序列组成的蛋白质的氨基末端或羧基末端连接上如表1所示的标签。In order to facilitate the purification of the protein in (a), the amino-terminus or carboxy-terminus of the protein consisting of the amino acid sequence shown in SEQ ID NO: 3 can be linked with the tags shown in Table 1.
表1标签及其序列Table 1 Tags and their sequences
上述(b)中的蛋白可人工合成,也可先合成其编码基因,再进行常规蛋白质表达得到。上述(b)中的蛋白的编码基因可能通过将SEQ ID NO:1或SEQ ID NO:2所示的DNA序列中缺失一个或几个编码氨基酸的密码子,和/或进行一个或几个碱基对的错义突变,和/或在其5’端和3’端连上表1所示的标签的编码序列而获得。The protein in (b) above can be synthesized artificially, or its coding gene can be synthesized first, and then conventional protein expression can be performed. The coding gene of the protein in the above (b) may be obtained by deleting one or several codons encoding amino acids in the DNA sequence shown in SEQ ID NO: 1 or SEQ ID NO: 2, and/or carrying out one or several bases Base pair missense mutations, and/or link the coding sequences of the tags shown in Table 1 at its 5' end and 3' end.
所述产油酵母ATP柠檬酸裂解酶Rt-ACL的氨基酸序列和编码核苷酸序列(rtacl,RHTO_03915.t1)均属于本发明的保护范围。优选地,所述蛋白的编码核苷酸序列为序列表中SEQ ID NO:1所示的DNA分子。The amino acid sequence and coding nucleotide sequence (rtacl, RHTO_03915.t1) of the oleaginous yeast ATP citrate lyase Rt-ACL both belong to the protection scope of the present invention. Preferably, the nucleotide sequence encoding the protein is the DNA molecule shown in SEQ ID NO: 1 in the sequence listing.
含有所述核苷酸序列的重组表达载体、表达盒、转基因细胞系或重组菌株均属于本发明的保护范围。Recombinant expression vectors, expression cassettes, transgenic cell lines or recombinant strains containing the nucleotide sequence all belong to the protection scope of the present invention.
因此,本发明还提供包含编码本发明的产油酵母ATP柠檬酸裂解酶的核苷酸序列的重组载体,优选是重组表达载体;提供导入了(例如,通过转化或转染技术导入)所述重组载体的重组细胞。Therefore, the present invention also provides a recombinant vector, preferably a recombinant expression vector, comprising a nucleotide sequence encoding the oleaginous yeast ATP citrate lyase of the present invention; Recombinant cells with recombinant vectors.
本领域技术人员应该理解,将编码产油酵母ATP柠檬酸裂解酶的核苷酸序列或包含编码产油酵母ATP柠檬酸裂解酶的核苷酸序列的重组载体导入宿主细胞可以按照本领域的常规技术进行,例如,可以通过转化、转染(例如,农杆菌介导的转染)或电穿孔等常规技术进行。Those skilled in the art should understand that the nucleotide sequence encoding oleaginous yeast ATP citrate lyase or the recombinant vector comprising the nucleotide sequence encoding oleaginous yeast ATP citrate lyase can be introduced into host cells according to the routine in the art Techniques are performed, for example, by conventional techniques such as transformation, transfection (eg, Agrobacterium-mediated transfection), or electroporation.
本发明还保护扩增所述基因的引物。The invention also protects primers for amplifying said genes.
可用现有的产油酵母、产油细菌和产油微藻表达载体构建含有所述编码基因(rtacl)的重组表达载体。所述的还包括根瘤农杆菌介导基因重组的载体和可用于基因敲除线性载体等。所述的表达载体还包含外源基因的3’端非翻译区域,即包含聚腺苷酸信号和任何其它参与mRNA加工或基因表达的DNA片段。所述聚腺苷酸信号可引导聚腺苷酸加入到mRNA前体的3’端,如农杆菌冠瘿瘤诱导(Ti)质粒基因(如胭脂合成酶Nos基因)、圆红冬孢酵母基因(如R.toruloides的G3PDH基因)3’端转录的非翻译区均具有类似功能。为了便于对转基因细胞系或重组菌株进行鉴定及筛选,可对所用载体进行修饰,如引入可在细胞中表达的编码产生颜色变化的酶(如绿色荧光蛋白)或发光化合物的基因(如GUS基因、荧光素酶基因等)、具有抗性的抗生素标记基因(如卡那霉素标记基因、博莱霉素标记基因、潮霉素标记基因)或抗化学试剂标记基因(如抗除莠剂基因)、以及营养筛选标记基因(如LEU2、URA3、URA3、LYS2、LYS5、MET15)等。The existing expression vectors of oleaginous yeast, oleaginous bacteria and oleaginous microalgae can be used to construct the recombinant expression vector containing the coding gene (rtacl). Said also includes the gene recombination vector mediated by Agrobacterium tumefaciens and the linear vector which can be used for gene knockout and the like. The expression vector also includes the 3' untranslated region of the foreign gene, that is, includes the polyadenylic acid signal and any other DNA fragments involved in mRNA processing or gene expression. The polyadenylic acid signal can guide polyadenylic acid to be added to the 3' end of the mRNA precursor, such as Agrobacterium crown gall tumor induction (Ti) plasmid gene (such as nopain synthase Nos gene), torusporidium toruloides gene (such as the G3PDH gene of R. toruloides) the untranslated regions transcribed at the 3' end have similar functions. In order to facilitate the identification and screening of transgenic cell lines or recombinant strains, the vectors used can be modified, such as introducing genes encoding color-changing enzymes (such as green fluorescent protein) or luminescent compounds (such as GUS gene) that can be expressed in cells. , luciferase gene, etc.), antibiotic marker genes with resistance (such as kanamycin marker gene, bleomycin marker gene, hygromycin marker gene) or chemical resistance marker genes (such as herbicide resistance gene ), and nutritional screening marker genes (such as LEU2, URA3, URA3, LYS2, LYS5, MET15), etc.
本发明的另一个目的是提供一种构建油脂生产重组细胞的方法,所述方法包括:将编码本发明的产油酵母ATP柠檬酸裂解酶的核苷酸序列导入宿主细胞,得到油脂生产重组细胞。利用任何一种可以启动外源基因在产油酵母中表达的载体,将本发明所提供rtacl导入产油酵母细胞中,得到油脂生产重组酵母。或者利用任何一种可以启动外源基因在产油细菌中表达的载体,将本发明所提供rtacl导入产油细菌细胞中,得到油脂生产重组细菌。。或者利用任何一种可以启动外源基因在产油微藻中表达的载体,将本发明所提供rtacl导入产油微藻中,得到油脂生产重组微藻菌株。Another object of the present invention is to provide a method for constructing a recombinant cell for oil production, the method comprising: introducing the nucleotide sequence encoding the oleaginous yeast ATP citrate lyase of the present invention into a host cell to obtain a recombinant cell for oil production . Using any vector capable of promoting the expression of foreign genes in oleaginous yeast, the rtacl provided by the present invention is introduced into oleaginous yeast cells to obtain oil-producing recombinant yeast. Or use any vector that can promote the expression of foreign genes in oleaginous bacteria, and introduce the rtacl provided by the present invention into oleaginous bacteria cells to obtain oil-producing recombinant bacteria. . Or use any vector that can promote the expression of exogenous genes in oleaginous microalgae, introduce the rtacl provided by the present invention into oleaginous microalgae, and obtain oil-producing recombinant microalgae strains.
实验证明,本发明提供的产油酵母ATP柠檬酸裂解酶可显著提高重组细胞的油脂含量。Experiments have proved that the oleaginous yeast ATP citrate lyase provided by the invention can significantly increase the oil content of recombinant cells.
综上所述,本发明提供下述:In summary, the present invention provides the following:
1.一种ATP柠檬酸裂解酶,所述ATP柠檬酸裂解酶是由如下(a)或(b)的蛋白质:1. ATP citrate lyase, described ATP citrate lyase is by following (a) or (b) protein:
(a)由SEQ ID NO:3所示的氨基酸序列组成的蛋白质;(a) a protein consisting of the amino acid sequence shown in SEQ ID NO: 3;
(b)将SEQ ID NO:3的氨基酸经过一个或几个氨基酸的取代和/或缺失和/或添加且与具有油脂贮运和代谢调控相关活性的由SEQ ID NO:3衍生的蛋白质。(b) The amino acid of SEQ ID NO: 3 undergoes one or several amino acid substitutions and/or deletions and/or additions, and is related to a protein derived from SEQ ID NO: 3 with activities related to lipid storage and transportation and metabolic regulation.
2.编码第1项所述的ATP柠檬酸裂解酶的核苷酸序列。2. A nucleotide sequence encoding the ATP citrate lyase described in item 1.
3.根据第2项所述的核苷酸序列,其为SEQ ID NO:1。3. The nucleotide sequence according to item 2, which is SEQ ID NO: 1.
4.包含第2项或第3项所述的核苷酸序列的重组载体。4. A recombinant vector comprising the nucleotide sequence described in item 2 or item 3.
5.一种重组细胞,所述细胞导入第4项所述的重组载体。5. A recombinant cell, which is introduced with the recombinant vector described in Item 4.
6.一种构建油脂生产重组细胞的方法,所述方法包括:将第2项或第3项所述的核苷酸序列导入宿主细胞中,得到油脂生产重组细胞。6. A method for constructing a recombinant cell for oil production, the method comprising: introducing the nucleotide sequence described in item 2 or item 3 into a host cell to obtain a recombinant cell for oil production.
7.根据第6项所述的方法,其中通过用第4项所述的重组载体转化宿主细胞而导入第2项或第3项所述的核苷酸序列。7. The method according to item 6, wherein the nucleotide sequence described in item 2 or 3 is introduced by transforming a host cell with the recombinant vector described in item 4.
8.根据第6项所述的方法,其中所述宿主细胞选自酵母、微藻、红球菌或大肠杆菌。8. The method according to item 6, wherein the host cell is selected from yeast, microalgae, Rhodococcus or Escherichia coli.
9.根据第8项所述的方法,其中所述酵母选自酿酒酵母(Saccharomyces cerevisiae)或圆红冬孢酵母(R.toruloides),所述微藻选自衣藻或聚球藻,所述红球菌是浑浊红球菌(R.opacus)。9. The method according to item 8, wherein the yeast is selected from Saccharomyces cerevisiae or R. toruloides, the microalgae are selected from Chlamydomonas or Synechococcus, the Rhodococcus is R. opacus.
10.根据第9项所述的方法,其中所述衣藻是莱茵衣藻(C.reinhardtii)。10. The method according to item 9, wherein the Chlamydomonas is C. reinhardtii.
序列表说明Description of sequence listing
SEQ ID NO:1ATP柠檬酸裂解酶基因Rt-ACL(cDNA序列)SEQ ID NO: 1 ATP citrate lyase gene Rt-ACL (cDNA sequence)
SEQ ID NO:2ATP柠檬酸裂解酶基因的基因组DNA序列SEQ ID NO: Genomic DNA sequence of 2ATP citrate lyase gene
SEQ ID NO:3ATP柠檬酸裂解酶的氨基酸序列SEQ ID NO: Amino acid sequence of 3ATP citrate lyase
附图说明Description of drawings
图1为扩增Rt-ACL cDNA的RT-PCR结果,扩增条带约为3.5kb。M为分子量标准,泳道1为R.toruloides Rt-ACL cDNA扩增产物。Figure 1 is the RT-PCR result of the amplified Rt-ACL cDNA, the amplified band is about 3.5kb. M is the molecular weight standard, and lane 1 is the amplification product of R.toruloides Rt-ACL cDNA.
图2为Rt-ACL cDNA与其它物种ATP柠檬酸裂解酶同源序列多重比对的分析结果。Figure 2 shows the analysis results of multiple alignments between Rt-ACL cDNA and homologous sequences of ATP citrate lyases from other species.
图3为扩增Rt-ACL gDNA的RT-PCR结果,扩增条带约为4.3kb。M为分子量标准,泳道1为R.toruloides Rt-ACL gDNA扩增产物。Figure 3 is the RT-PCR result of the amplified Rt-ACL gDNA, the amplified band is about 4.3kb. M is the molecular weight standard, and lane 1 is the amplified product of R.toruloides Rt-ACL gDNA.
图4为Rt-ACL cDNA在酿酒酵母中表达载体pYX212-Rt-ACL的构建。Fig. 4 is the construction of Rt-ACL cDNA expression vector pYX212-Rt-ACL in Saccharomyces cerevisiae.
图5为在酿酒酵母中测定rtaclp活性结果。每组数据均为三株重组菌株测定平均值。pYX212为仅表达pYX212空载体的酿酒酵母菌株,pYX212-ACL为表达pYX212-ACL的酿酒酵母菌株。Figure 5 is the result of measuring rtaclp activity in Saccharomyces cerevisiae. Each set of data is the average value of three recombinant strains. pYX212 is a strain of Saccharomyces cerevisiae expressing only pYX212 empty vector, and pYX212-ACL is a strain of Saccharomyces cerevisiae expressing pYX212-ACL.
具体实施方式Detailed ways
以下实施例将有助于本领域的普通技术人员进一步理解本发明,但不以任何形式限制本发明。下述实施例中的实验方法,如无特殊说明,均为常规方法。下述实施例中所用的实验材料,如无特殊说明,均为自常规生化试剂公司购买得到的。The following examples will help those of ordinary skill in the art to further understand the present invention, but do not limit the present invention in any form. The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples were purchased from conventional biochemical reagent companies unless otherwise specified.
圆红冬孢酵母(R.toruloides)CGMCC2.1389:购自中国普通微生物菌种保藏中心(CGMCC,保藏号为CGMCC2.1389),源自东京大学应用微生物研究所(IFO8766),由IFO0559和IFO0880经配合而成的二倍体,等同于CBS6016或NBRC8766或NRRL Y-6987。Rhodosporidium toruloides (R.toruloides) CGMCC2.1389: purchased from China General Microorganism Culture Collection Center (CGMCC, preservation number is CGMCC2.1389), from the Institute of Applied Microbiology, University of Tokyo (IFO8766), from IFO0559 and IFO0880 The diploid formed by mating is equivalent to CBS6016 or NBRC8766 or NRRL Y-6987.
圆红冬孢酵母(R.toruloides)ATCC10788:购自美国典型培养物保藏中心(ATCC),源自CBS-KNAW fungal biodiversity centre,等同于IFO0559或JCM3792或CCRC20306或DBVPG6740或IAM13469或IGC4416或MUCL30249或NCYC921或NRRL Y-1091或VKM Y-334或PYCC4416。Rhodosporidium toruloides (R. toruloides) ATCC10788: purchased from American Type Culture Collection (ATCC), derived from CBS-KNAW fungal biodiversity centre, equivalent to IFO0559 or JCM3792 or CCRC20306 or DBVPG6740 or IAM13469 or IGC4416 or MUCL30249 or NCYC921 Or NRRL Y-1091 or VKM Y-334 or PYCC4416.
以下实施例中所涉及的培养基配方及用途如下:The culture medium formulation and purposes involved in the following examples are as follows:
(1)YEPD培养基:酵母粉10g/L,蛋白胨10g/L,葡萄糖20g/L,pH6.0,固体培养基则再加入琼脂粉15g/L;用于菌种活化培养、种子液制备和菌种短期保藏。(1) YEPD medium: Yeast powder 10g/L, peptone 10g/L, glucose 20g/L, pH6.0, solid medium then add agar powder 15g/L; used for strain activation culture, seed liquid preparation and Short-term storage of strains.
(2)限氮培养基:葡萄糖70g/L,酵母粉0.75g/L,(NH4)2SO40.1g/L,KH2PO41.0g/L,MgSO4·7H2O1.5g/L,pH5.6,并补加1%(V/V)的痕量元素液体(4.0g/L CaCl2·2H2O,0.55g/L FeSO4·7H2O,0.52g/L citric acid·H2O,0.10g/L ZnSO4·7H2O,0.076g/L MnSO4·H2O和100μl 18MH2SO4),用于菌株油脂积累和富含脂滴菌体的培养。(2) Nitrogen-limited medium: glucose 70g/L, yeast powder 0.75g/L, (NH4)2SO40.1g/L, KH2PO41.0g/L, MgSO4·7H2O1.5g/L, pH5.6, and supplemented 1% (V/V) trace element liquid (4.0g/L CaCl2 2H2O, 0.55g/L FeSO4 7H2O, 0.52g/L citric acid H2O, 0.10g/L ZnSO4 7H2O, 0.076g/L MnSO4·H2O and 100μl 18MH2SO4), used for strain oil accumulation and culture of lipid-rich bacteria.
实施例1:圆红冬孢酵母的多组学研究Example 1: Multi-omics study of Rhodosporidium toruloides
圆红冬孢酵母(R.toruloides)全基因组从头测序:在YEPD培养基中培养R.toruloides ATCC10788,温度为30℃,转速200rpm,培养时间48h。收集菌体,按标准基因组DNA提取方法[精编分子生物学实验指南(第四版),奥斯伯等著,颜子颖等译,科学出版社出版]制备基因组DNA,委托华大基因利用solexa测序仪进行分析,最终获得94个scaffold(基因组构架),基因组全长20.2Mb。Whole-genome de novo sequencing of Rhodosporidium toruloides (R.toruloides): R.toruloides ATCC10788 was cultured in YEPD medium at a temperature of 30°C, a rotational speed of 200 rpm, and a culture time of 48 hours. Collect bacteria, prepare genomic DNA according to the standard genomic DNA extraction method [Refined Molecular Biology Experiment Guide (Fourth Edition), Osper et al., Yan Ziying et al., Translated by Science Press], and entrust BGI to use solexa sequencing The instrument was analyzed, and finally 94 scaffolds (genome framework) were obtained, with a total genome length of 20.2Mb.
圆红冬孢酵母(R.toruloides)转录组测序:在2L发酵罐中(初始培养基量1.7L),温度为30℃,pH为5.6的条件下恒化培养R.toruloidesATCC10788,通气速率为100L/h,溶氧保持为73%饱和(溶氧与搅拌联动),YEPD培养基流加速率为0.828L/h(稀释率为0.53)(反应器工作体积为1.7L)。约10个工作体积后取样,离心收集菌体,立即于液氮中速冻,-70℃保存,干冰低温保存运输至华大基因(全名:北京六合华大基因科技股份有限公司深圳分公司)。采用液氮研磨-RNAiso法提取总RNA,RNA-seq样品库的制备使用mRNA-Seq8Sample Preparation Kit(购自Illumina,San Diego,CA,USA),具体步骤参考产品使用说明。之后经Illumina HiSeq2000测序得到90bp的双末端序列。Transcriptome sequencing of Rhodosporidium toruloides (R. toruloides): culture R. toruloidesATCC10788 in a 2L fermenter (initial medium volume 1.7L), temperature 30°C, pH 5.6, and aeration rate 100L /h, the dissolved oxygen is maintained at 73% saturation (dissolved oxygen and stirring linkage), the YEPD medium flow acceleration rate is 0.828L/h (dilution rate is 0.53) (the working volume of the reactor is 1.7L). After about 10 working volumes, samples were taken, the bacteria were collected by centrifugation, and immediately frozen in liquid nitrogen, stored at -70°C, stored on dry ice and transported to Huada Gene (full name: Beijing Liuhe Huada Gene Technology Co., Ltd. Shenzhen Branch) . Total RNA was extracted by liquid nitrogen grinding-RNAiso method, and the mRNA-Seq8 Sample Preparation Kit (purchased from Illumina, San Diego, CA, USA) was used to prepare the RNA-seq sample library. For specific steps, refer to the product instructions. Afterwards, a 90bp paired-end sequence was obtained by Illumina HiSeq2000 sequencing.
基于R.toruloides全基因组从头测序和转录组测序数据,组合基因从头预测,共注释了8171个蛋白编码基因。利用Bioedit软件建立R.toruloides本地基因组数据库和蛋白质组数据库。基因和蛋白命名规则如下:根据注释基因所在scaffold(基因组构架)由大到小进行编码,编号前统一加上R.toruloides的两个单词前两个字母缩写,转录本和蛋白质后分别加.t1和.t1p的后缀。比如,scaffold1上5’端起第一个编码基因命名为RHTO_00001,对应的转录本为RHTO_00001.t1,相应编码的蛋白质序列为RHTO_00001.t1p。数据库包含94个scaffold(基因组构架),8171个编码基因及相应8171个蛋白。Based on the whole genome de novo sequencing and transcriptome sequencing data of R. toruloides, combined with de novo gene prediction, a total of 8171 protein-coding genes were annotated. The R.toruloides local genome database and proteome database were established using Bioedit software. The naming rules of genes and proteins are as follows: according to the scaffold (genome framework) where the annotated genes are located, they are coded from large to small, and the first two letters of the two words of R.toruloides are uniformly added before the number, and .t1 is added after transcripts and proteins. and .t1p suffix. For example, the first coding gene from the 5' end of scaffold1 is named RHTO_00001, the corresponding transcript is RHTO_00001.t1, and the corresponding encoded protein sequence is RHTO_00001.t1p. The database contains 94 scaffolds (genome framework), 8171 coding genes and corresponding 8171 proteins.
实施例2:圆红冬孢酵母ACL基因的发现Embodiment 2: Discovery of Rhodosporidium toruloides ACL gene
R.toruloides ATCC10788于YEPD固体培养基上复苏,30℃倒置培养48h,挑单菌落接种于50ml YEPD液体培养基(装液于250ml容量的三角瓶),30℃,200rpm培养28h。培养液分别以1∶50(V/V)比例转接于自动补料的2L连续发酵罐(工作体积1.7L),培养基分别为MM和MM-N。恒化培养温度为30℃,pH通过滴加10.0M NaOH或2M HCl自动控制在5.6,转速保持为600rpm,通气速率为100L/h(约0.98VVM),溶氧保持为85%饱和,稀释率为0.085。约15个工作体积后取样,样品经4℃,8000rpm离心5min收集,每45ml培养物能收集到约0.7g湿菌体,MM和MM-N菌体样品均立即于液氮中速冻,-70℃保存。菌体样品用于数字基因表达谱分析,以及胞内油脂含量分析,培养上清用于残氮分析[沈宏伟,靳国杰,胡翠敏,龚志伟,白凤武,赵宗保.生物工程学报2012,28(1),57-65]。R. toruloides ATCC10788 was revived on YEPD solid medium, cultured upside down at 30°C for 48 hours, picked a single colony and inoculated in 50ml YEPD liquid medium (filled in a 250ml Erlenmeyer flask), and cultured at 30°C, 200rpm for 28h. The culture medium was transferred to a 2L continuous fermenter (working volume 1.7L) with automatic feeding at a ratio of 1:50 (V/V), and the medium was MM and MM-N respectively. The temperature of the chemostat culture is 30°C, the pH is automatically controlled at 5.6 by dropping 10.0M NaOH or 2M HCl, the rotation speed is maintained at 600rpm, the ventilation rate is 100L/h (about 0.98VVM), the dissolved oxygen is maintained at 85% saturation, and the dilution rate is 0.085. After about 15 working volumes, samples were collected. The samples were collected by centrifugation at 4°C and 8000rpm for 5 minutes. About 0.7g of wet bacteria could be collected per 45ml of culture. Both MM and MM-N bacteria samples were immediately frozen in liquid nitrogen, -70 Store at ℃. Bacterial samples were used for digital gene expression profile analysis and intracellular lipid content analysis, and culture supernatant was used for residual nitrogen analysis [Shen Hongwei, Jin Guojie, Hu Cuimin, Gong Zhiwei, Bai Fengwu, Zhao Zongbao. Journal of Bioengineering 2012, 28(1) , 57-65].
在实施例1基础上,菌体样品委托华大基因提取RNA后进行R.toruloides在限氮和非限氮培养条件下的数字基因表达谱分析。样品重复分析三次,数据分析基于三次重复分析中鉴定到的差异表达基因累加。On the basis of Example 1, the bacteria samples were commissioned by BGI to extract RNA and then conduct digital gene expression profiling analysis of R. toruloides under nitrogen-limited and non-nitrogen-limited culture conditions. Samples were analyzed in triplicate, and data analysis was based on the accumulation of differentially expressed genes identified in the triplicate analyses.
结果显示,R.toruloides np11使用MM和MM-N这两种培养基进行恒化培养时,油脂含量有显著的差别,限氮培养(MM-N培养)条件下,细胞积累的油脂量为33.3%,比非限氮培养(MM培养)条件下提高了22.8%。通过检测培养液上清中氮的浓度表明非限氮条件下氮浓度为46.97mM,而限氮(MM-N)条件下,其氮的浓度已经低于检测限,表明菌体培养时采用了一种稳定的限氮与非限氮环境。The results showed that when R.toruloides np11 was cultured with MM and MM-N, there was a significant difference in the oil content. %, which is 22.8% higher than that under the condition of non-limiting nitrogen culture (MM culture). By detecting the concentration of nitrogen in the supernatant of the culture solution, it shows that the nitrogen concentration is 46.97mM under the condition of non-limiting nitrogen, while under the condition of nitrogen limitation (MM-N), the concentration of nitrogen has been lower than the detection limit, which indicates that the bacterium was cultivated using the A stable nitrogen-limited and non-nitrogen-limited environment.
剔除含N碱基和低质量数据后,数字基因表达谱分析得到119192(MM-N)和92644条(MM)条差异的clean Tag。在这些clean Tag的基础下进行了下面的分析,将Tag定位匹配到参考基因上,以获得基因的表达量,无法定位匹配到基因上的Tag,则将其定位匹配到基因组上,最后均不能匹配的Tag则认为是未知的Tag。过滤后得到56846个MM Tag(总数3454492个)和60010个MM-N Tag(总数为3600362个)。经过归一化处理,和统计检验,选取表达丰度比≥2,控制假阳性FDR≤0.001最终得到表达上调基因1176个,其中有三个表达丰度比≥10的Tag:CATGCCGCACTCGCCGGCCCC,CATGCAGGACATCGAGGTCGT,和ATCTTCATCCAGCCCTTCA,分别来源于三个核苷酸序列长度为3.8kb,8.8kb和3.4kb的转录本(R.toruloides本地转录组数据库中编号为RHTO_02032.t1,RHTO_02139.t1,和RHTO_03915.t1),分别编码脂肪酸合酶beta亚基,alpha亚基及ATP柠檬酸裂解酶蛋白。其中,RHTO_03915.t1表达量随脂滴内油脂含量增加而增加,其编码的氨基酸序列如SEQ ID NO:3所示,命名为rtaclp。其编码基因命名为RT-ACL cDNA。After removing N bases and low-quality data, 119,192 (MM-N) and 92,644 (MM) differential clean Tags were obtained by digital gene expression profiling analysis. On the basis of these clean Tags, the following analysis is carried out, and the Tag positioning is matched to the reference gene to obtain the expression level of the gene. If the Tag that cannot be located and matched to the gene is located, its positioning is matched to the genome, and finally it cannot be A matching Tag is considered an unknown Tag. After filtering, 56,846 MM Tags (3,454,492 in total) and 60,010 MM-N Tags (3,600,362 in total) were obtained. After normalization processing and statistical testing, select the expression abundance ratio ≥ 2, control the false positive FDR ≤ 0.001, and finally get 1176 up-regulated genes, including three Tags with an expression abundance ratio ≥ 10: CATG CCGCACTCGCCGGCCCC, CATG CAGGACATCGAGGTCGT, and ATCT TCATCCAGCCCTTCA, derived from three transcripts with nucleotide sequence lengths of 3.8kb, 8.8kb and 3.4kb, respectively (numbers RHTO_02032.t1, RHTO_02139.t1, and RHTO_03915.t1 in the R. toruloides local transcriptome database) , respectively encoding fatty acid synthase beta subunit, alpha subunit and ATP citrate lyase protein. Among them, the expression level of RHTO_03915.t1 increases with the increase of lipid content in the lipid droplet, and its encoded amino acid sequence is shown in SEQ ID NO: 3, named rtaclp. The coding gene was named RT-ACL cDNA.
实施例3:圆红冬孢酵母AS2.1389RT-ACL基因组DNA的获取Example 3: Acquisition of Rhodosporidium toruloides AS2.1389RT-ACL genomic DNA
根据Rt-ACL的核苷酸序列设计基因特异性引物如下:Design gene-specific primers according to the nucleotide sequence of Rt-ACL as follows:
ACL-orf-P1:5’-ATGTCGGCAAAGCCTATCCGCGA-3’ACL-orf-P1: 5'-ATGTCGGCAAAGCCTATCCGCGA-3'
ACL-orf-P2:5’-CTACTGGCGCTGCTGGACGAGGAT-3’ACL-orf-P2: 5'-CTACTGGCGCTGCTGGACGAGGAT-3'
按照“精编分子生物学实验指南(第四版)(奥斯伯等著,颜子颖等译,科学出版社出版)”描述方法提取圆红冬孢酵母AS2.1389的基因组DNA,紫外/可见光光谱分析测得样品OD260/OD280=1.88,表明基因组DNA质量很好。冻存于-20℃,备用。Genomic DNA of Rhodosporidium toruloides AS2.1389 was extracted according to the method described in "Guide to Molecular Biology Experiments (Fourth Edition) (Osper et al., translated by Yan Ziying, et al., published by Science Press), UV/visible light spectrum Analysis showed that OD 260 /OD 280 of the sample was 1.88, indicating that the genomic DNA was of good quality. Freeze at -20°C for later use.
以圆红冬孢酵母AS2.1389的基因组DNA为模板,利用ACL-orf-P1和ACL-orf-P2两条引物,按照常规方法进行PCR扩增,得到约4.3kb的PCR(图3)。PCR扩增产物按照实施例2的操作步骤回收、克隆到pMD18-T载体中,并进行测序,测序结果表明,所扩增到的核苷酸序列为SEQ IDNO:2,长度为4428bp。将SEQ ID NO:2所示的核苷酸命名为RT-ACLgDNA,获得的阳性重组质粒命名为pMD18T-RTACLg。Using the genomic DNA of Rhodosporidium toruloides AS2.1389 as a template, using two primers ACL-orf-P1 and ACL-orf-P2, PCR amplification was performed according to conventional methods, and a PCR of about 4.3 kb was obtained (Fig. 3). The PCR amplification product was recovered according to the operation steps in Example 2, cloned into the pMD18-T vector, and sequenced. The sequencing results showed that the amplified nucleotide sequence was SEQ ID NO: 2, and the length was 4428bp. The nucleotide shown in SEQ ID NO: 2 was named RT-ACLgDNA, and the obtained positive recombinant plasmid was named pMD18T-RTACLg.
实施例4:圆红冬孢酵母RT-ACL基因的功能验证Example 4: Functional verification of Rhodosporidium toruloides RT-ACL gene
根据RT-ACL的核苷酸序列设计以下引物,用于构建RT-ACL在酿酒酵母中表达的载体(引物ACL-PYX-BamH I的下划线部分为BamH I酶切位点,引物ACL-PYX-HindIII的下划线部分为HindIII酶切位点):Design the following primers according to the nucleotide sequence of RT-ACL, be used to construct the vector that RT-ACL expresses in Saccharomyces cerevisiae (the underlined part of primer ACL-PYX-BamH I is the BamH I restriction site, primer ACL-PYX- The underlined part of HindIII is the HindIII restriction site):
ACL-PYX-BamH I:5’-TCAGGGATCCAAAAATGTCGGCAAAGCCTATCCGCGA-3’ACL-PYX-BamH I: 5'-TCAG GGATCC AAAAATGTCGGCAAAGCCTATCCGCGA-3'
ACL-PYX-HindIII:5’-ACTGAAGCTTCTAATGGTGATGGTGATGATGCTGGCGCTGCTGGACGAGG-3’ACL-PYX-HindIII: 5'-ACTG AAGCTT CTAATGGTGATGGTGATGATGCTGGCGCTGCTGGACGAGG-3'
步骤一RT-ACL酵母重组载体pYX212-Rt-ACL的构建Step 1 Construction of RT-ACL yeast recombinant vector pYX212-Rt-ACL
采用ACL-PYX-BamH I和ACL-PYX-HindIII两个引物扩增片段,经BamHI/HindIII双酶切后连入同样酶切的pYX212(购自Biovector)。将经BamHI/HindIII酶切鉴定可释放出约3.5kb插入片段的重组质粒送TaKaRa测序,测序正确的重组质粒命名为pYX212-ACL(图4)。ACL-PYX-BamH I and ACL-PYX-HindIII primers were used to amplify the fragment, and after double digestion with BamHI/HindIII, it was ligated into the same digested pYX212 (purchased from Biovector). The recombinant plasmid that released about 3.5kb insert fragment identified by BamHI/HindIII digestion was sent to TaKaRa for sequencing, and the correctly sequenced recombinant plasmid was named pYX212-ACL (Figure 4).
步骤二RT-ACL重组酵母表达菌株的构建Step 2 Construction of RT-ACL recombinant yeast expression strain
将pYX212-ACL转化至Saccharomyces cerevisiae INVSc1(购自Invitrogen,基因型:MATa/α,his3Δ1/his3Δ1,leu2/leu2,trp1-289/trp1-289,ura3-52/ura3-52)中。转化方法如下:单个酵母菌落接种于5ml YPD培养基(20g/L蛋白胨,10g/L酵母提取物和20g/L葡萄糖,pH6.0),过夜培养;以1∶50接种于100ml新鲜的YPD培养基,培养8h左右,此时OD值约为1.0-1.2,冰浴15min;4℃,2000×g离心10min收集菌体,悬浮于50ml冰冷的ddH2O,2000×g离心10min离心收集菌体,然后悬浮于20ml冰冷的1M山梨醇,2000×g离心10min离心收集菌体,倒尽溶液,菌体悬浮于0.5-1.0ml冰冷的山梨醇,此时OD值约为100-200。50μl电转感受态细胞中加入不多于5μl质粒DNA(0.5-1μg),冰上放置10min,转移至冰冷的电转杯中,1500V电压转化,此条件下电击时间约为5ms,电击完加入1ml冰冷的山梨醇,于30℃摇床温浴2h,涂于SC-Uracil平板(20g/L glucose,6.7g/L YNB W/O amino acids but with ammonium sulfate(无氨基酸酵母基础氮源,含硫酸铵,购自BD Dific,货号:291920),1.9g/L Yeast Synthetic Drop-out Medium Supplements(购自sigma,货号Y1501)),30℃培养3-4天至长出转化子。转化子接种于SC-Ura液体培养基(0.67%YNB W/O amino acids but with ammonium sulfate(同上),2%葡萄糖,0.01%亮氨酸,0.01%色氨酸,0.005%组氨酸)过夜,3-4ml菌液离心收集菌体,玻璃珠破碎细胞,提取质粒DNA转化E.coli DH5a,转化子提取质粒,BamHI/HindIII酶切验证正确的质粒来源重组菌则命名为INVSc1-pYX212-ACL。pYX212-ACL was transformed into Saccharomyces cerevisiae INVSc1 (purchased from Invitrogen, genotype: MATa/α, his3Δ1/his3Δ1, leu2/leu2, trp1-289/trp1-289, ura3-52/ura3-52). The transformation method is as follows: a single yeast colony is inoculated in 5ml YPD medium (20g/L peptone, 10g/L yeast extract and 20g/L glucose, pH 6.0), cultured overnight; inoculated at 1:50 in 100ml fresh YPD medium At this time, the OD value is about 1.0-1.2, and the ice bath is 15 minutes; 4°C, 2000×g centrifugation for 10 minutes to collect the bacteria, suspend in 50ml ice-cold ddH 2 O, and centrifuge at 2000×g for 10 minutes to collect the bacteria , then suspended in 20ml of ice-cold 1M sorbitol, centrifuged at 2000×g for 10min to collect the cells, poured out the solution, and suspended the cells in 0.5-1.0ml of ice-cold sorbitol, at this time the OD value was about 100-200. 50μl electroporation Add no more than 5 μl of plasmid DNA (0.5-1 μg) to the competent cells, place on ice for 10 minutes, transfer to an ice-cold electroporation cup, and transform with a voltage of 1500V. Under this condition, the electric shock time is about 5ms. After electric shock, add 1ml of ice-cold sorrel Alcohol, incubating on a shaker at 30°C for 2h, spread on SC-Uracil plate (20g/L glucose, 6.7g/L YNB W/O amino acids but with ammonium sulfate (basic nitrogen source of yeast without amino acid, containing ammonium sulfate, purchased from BD Dific, product number: 291920), 1.9g/L Yeast Synthetic Drop-out Medium Supplements (purchased from sigma, product number Y1501)), cultured at 30°C for 3-4 days until transformants grew out. Transformants were inoculated in SC-Ura liquid medium (0.67% YNB W/O amino acids but with ammonium sulfate (same as above), 2% glucose, 0.01% leucine, 0.01% tryptophan, 0.005% histidine) overnight , 3-4ml bacterial liquid was collected by centrifugation, the cells were broken with glass beads, the plasmid DNA was extracted and transformed into E.coli DH5a, the transformants were extracted with plasmids, and the recombinant bacteria were named INVSc1-pYX212-ACL after digestion with BamHI/HindIII to verify the correct source of the plasmid. .
步骤三酶液的制备Step 3 Preparation of Enzyme Solution
将正确的重组菌株INVSc1-pYX212-ACL接种于5ml SC-Ura液体培养基作为种子夜,培养过夜。而后以1∶100(v/v)的接种量接入100mlSC-Ura液体培养基中,至OD值达到4.2。The correct recombinant strain INVSc1-pYX212-ACL was inoculated in 5ml SC-Ura liquid medium as a seed night and cultivated overnight. Then inoculated into 100ml SC-Ura liquid medium with an inoculation amount of 1:100 (v/v) until the OD value reached 4.2.
将菌液离心弃上清,并用同体积蒸馏水洗涤一遍。用提取缓冲液(50Mm Tris-HCl(pH8.0)、1mM EDTA、10mM DTT、1mM PMSF)5ml悬浮,使用费氏压碎器用12kPa破碎菌体。20,000g,4℃离心分离15min,收集上清。于填充了Shehadex G-25的PD-10色谱柱(GEHEALTHCAREBIO-SCIENCES公司),用洗脱缓冲液(10mM磷酸钠(pH7.4)、1mM MgCl2、0.1mM EDTA、1mM DTT)洗脱,洗脱液作为酶液。The supernatant was discarded from the bacterial solution and washed once with the same volume of distilled water. Suspend in 5 ml of extraction buffer (50 Mm Tris-HCl (pH 8.0), 1 mM EDTA, 10 mM DTT, 1 mM PMSF), and crush the bacterial cells at 12 kPa using a Fischer crusher. Centrifuge at 20,000g for 15 minutes at 4°C and collect the supernatant. On a PD-10 chromatographic column filled with Shehadex G-25 (GEHEALTHCAREBIO-SCIENCES Company), use elution buffer (10mM sodium phosphate (pH7.4), 1mM MgCl 2 , 0.1mM EDTA, 1mM DTT) to elute, elute Remove the liquid as the enzyme solution.
步骤四ACL活性测定Step 4 ACL Activity Determination
ACL的活性是通过其催化柠檬酸生成的草酰乙酸的量,进一步由苹果酸脱氢酶催化草酰乙酸与NADH反应过程中NADH减少的量来求出的。NADH的变化量可以通过在A340处的变化来求出。The activity of ACL is determined by the amount of oxaloacetate it catalyzes the generation of citric acid, and the amount of NADH reduction in the reaction process of oxaloacetate and NADH catalyzed by malate dehydrogenase. The amount of change in NADH can be calculated from the change at A340 .
反应式如下:The reaction formula is as follows:
(1)柠檬酸+CoA+ATP→草酰乙酸+ADP+Pi+乙酰CoA(1) Citric acid + CoA + ATP → oxaloacetic acid + ADP + Pi + acetyl CoA
(2)草酰乙酸+NADH→苹果酸+NAD+ (2) Oxaloacetic acid + NADH → malic acid + NAD +
反应液的组成为10mM Tris-HCl(pH8.4)、10mM MgCl2、1mM DTT、10mMATP、10mM柠檬酸、0.2mM CoA、6单位苹果酸脱氢酶、0.1mMNADH、50μl酶液,总量为1ml。添加CoA使反应开始,反应在28℃下进行。The composition of the reaction solution is 10mM Tris-HCl (pH8.4), 10mM MgCl 2 , 1mM DTT, 10mM ATP, 10mM citric acid, 0.2mM CoA, 6 units of malate dehydrogenase, 0.1mMNADH, 50μl enzyme solution, the total amount is 1ml. Addition of CoA started the reaction, which was carried out at 28°C.
结果如图5所示,可以看出仅在酿酒酵母中表达空载体pYX212的菌株不能测定到ACL的活性,相反,表达了pYX212-ACL的菌株显示出ACL的活性,并且具有显著性。因此我们可以判定表达的Rt-ACL蛋白能够在酿酒酵母中起到分解柠檬酸裂解为草酰乙酸和乙酰CoA的作用,即具有ATP柠檬酸裂解酶的活性。The results are shown in Figure 5. It can be seen that only the strain expressing the empty vector pYX212 in Saccharomyces cerevisiae could not detect the activity of ACL, on the contrary, the strain expressing pYX212-ACL showed the activity of ACL, and it was significant. Therefore, we can determine that the expressed Rt-ACL protein can decompose citric acid into oxaloacetate and acetyl CoA in Saccharomyces cerevisiae, that is, it has the activity of ATP citrate lyase.
实施例5:Rt-ACL表达重组圆红冬孢酵母菌株的构建Embodiment 5: Construction of Rt-ACL expression recombinant Rhodosporidium toruloides strain
根据Rt-ACL的核苷酸序列设计以下引物(引物FBA-F-SpeI的下划线部分为SpeI酶切位点,引物ACL-R-EcoRV的下划线部分为EcoRV酶切位点):Design the following primers according to the nucleotide sequence of Rt-ACL (the underlined part of the primer FBA-F-SpeI is the SpeI restriction site, and the underlined part of the primer ACL-R-EcoRV is the EcoRV restriction site):
FBA-F-SpeI:5’-ACTGACTAGTCTCTGCTCTCGCTCGCTGTGGCTTG-3’FBA-F-SpeI: 5'-ACTG ACTAGTCTCTGCTCTCGCTCGCTGTGGCTTG -3'
FBA-R:5’-GATTCCACGCACCTTTGCCGACATTGTAGCTAGTTAGTGTTAGAAGTG-3’FBA-R: 5’-GATTCCACGCACCTTTGCCGACATTGTAGCTAGTTAGTGTTAGAAGTG-3’
ACL-F:5’-CACTTCTAACACTAACTAGCTACAATGTCGGCAAAGGTGCGTGGAATC-3’ACL-F: 5'-CACTTCTAACACTAACTAGCTACAATGTCGGCAAAGGTGCGTGGAATC-3'
ACL-R-EcoRV:5’-CCGTGATATCCTACTGGCGCTGCTGGACGAGG-3’ACL-R-EcoRV: 5'-CCGT GATATC CTACTGGCGCTGCTGGACGAGG-3'
引物方向均为5’至3’方向。The primers were all in the 5' to 3' direction.
以实施例3中构建的克隆载体pMD18T-RTACLg为模板,利用引物ACL-F和ACL-R-EcoRV扩增RT-ACL序列,另以圆红冬孢酵母AS2.1389基因组为模板,采用引物FBA-F-SpeI和FBA-R扩增FBA启动子区域。两个PCR片段利用文献[Zhou YJ,Gao W,et al.J.Am.Chem.Soc2012,134:3234-3241.]中的方法进行融合。获得的融合片段经EcoRV/SpeI双酶切,连接入同样双酶切的pRH203[Liu Y,Koh CM,Sun L,Hlaing MM,Du M,Peng N,Ji L.Appl Microbiol Biotechnol.2013Jan;97(2):719-729]载体中。连接产物转化E.coli DH5a化学感受态细胞,挑选链霉素抗性转化子进行增菌培养、质粒提取(碧云天质粒小量提取试剂盒,货号:D0003)。重组质粒样品送至TaKaRa公司测序,经测序验证正确构建的重组质粒命名为pRH203-RTACLg。Using the cloning vector pMD18T-RTACLg constructed in Example 3 as a template, use the primers ACL-F and ACL-R-EcoRV to amplify the RT-ACL sequence, and use the Rhodosporidium toruloides AS2.1389 genome as a template and use the primer FBA -F-SpeI and FBA-R amplify the FBA promoter region. The two PCR fragments were fused using the method in the literature [Zhou YJ, Gao W, et al. J. Am. Chem. Soc2012, 134: 3234-3241.]. The obtained fusion fragment was digested by EcoRV/SpeI and ligated into pRH203 [Liu Y, Koh CM, Sun L, Hlaing MM, Du M, Peng N, Ji L. Appl Microbiol Biotechnol.2013Jan; 97( 2): 719-729] in vector. The ligation product was transformed into E.coli DH5a chemically competent cells, and the streptomycin-resistant transformants were selected for enrichment culture and plasmid extraction (Biyuntian Plasmid Small Extraction Kit, Cat. No.: D0003). The recombinant plasmid samples were sent to TaKaRa Company for sequencing, and the correctly constructed recombinant plasmid was named pRH203-RTACLg after sequencing verification.
将pRH203-RTACLg转化农杆菌AGL1[Lazo GR,Stein PA,Ludwig RA.Biotechnology(N Y).1991,9(10),963-967.]。挑取壮观霉素抗性转化子,利用引物ACL-F和ACL-R-EcoRV进行PCR鉴定,阳性重组子命名为AGL1/pRH203-RTACLg。pRH203-RTACLg was transformed into Agrobacterium AGL1 [Lazo GR, Stein PA, Ludwig RA. Biotechnology (NY). 1991, 9(10), 963-967.]. Spectinomycin-resistant transformants were picked and identified by PCR using primers ACL-F and ACL-R-EcoRV, and the positive recombinant was named AGL1/pRH203-RTACLg.
将重组农杆菌AGL1/pRH203-RTACLg按Yanbin Liu等人方法转化导入圆红冬孢酵母R.toruloides ATCC10788,挑取潮霉素抗性转化子进行PCR鉴定,阳性重组子命名为R.toruloides ATCC10788RTACLg[Liu Y,Koh CM,Sun L,Hlaing MM,Du M,Peng N,Ji L.Appl Microbiol Biotechnol.2013Jan;97(2):719-729]。The recombinant Agrobacterium AGL1/pRH203-RTACLg was transformed into Rhodosporidium toruloides ATCC10788 according to the method of Yanbin Liu et al., and hygromycin-resistant transformants were picked for PCR identification. The positive recombinant was named R.toruloides ATCC10788RTACLg[ Liu Y, Koh CM, Sun L, Hlaing MM, Du M, Peng N, Ji L. Appl Microbiol Biotechnol. 2013 Jan;97(2):719-729].
将出发菌株圆红冬孢酵母R.toruloides ATCC10788和重组圆红冬孢酵母R.toruloides ATCC10788RTACLg分别接种YEPD培养基,30℃,200rpm,培养3d,每隔24h取样,留做油脂含量分析和荧光观测[Wu SG,ZhaoX,Shen HW,Wang Q,Zhao ZK.Bioresour.Technol.2011,102(2),1803-1807.]。结果发现,在不利于油脂积累的YEPD培养条件下,与对照菌株ATCC10788相比,重组圆红冬孢酵母ATCC10788RTACLg胞内油脂含量由14%增加到了35%,增加了2.5倍。这证明RL-ACL基因可促进圆红冬包酵母油脂含量显著增加。The starting strain R. toruloides ATCC10788 and the recombinant R. toruloides ATCC10788RTACLg were inoculated into YEPD medium respectively, cultured at 30°C and 200 rpm for 3 days, and samples were taken every 24 hours for oil content analysis and fluorescence observation [Wu SG, Zhao X, Shen HW, Wang Q, Zhao ZK. Bioresour. Technol. 2011, 102(2), 1803-1807.]. It was found that under the YEPD culture conditions that are not conducive to oil accumulation, compared with the control strain ATCC10788, the intracellular oil content of recombinant Rhodosporidium toruloides ATCC10788RTACLg increased from 14% to 35%, an increase of 2.5 times. This proves that the RL-ACL gene can promote a significant increase in the oil content of R. toruloides.
实施例6:Rt-ACL重组浑浊红球菌的构建Embodiment 6: Construction of Rt-ACL recombinant Rhodococcus opacus
根据Rt-ACL的编码核苷酸序列设计以下引物(引物ACL-F-BamHI的下划线部分为BamHI酶切位点,引物ACL-R-XbaI的下划线部分为XbaI酶切位点):Design the following primers according to the coding nucleotide sequence of Rt-ACL (the underlined part of the primer ACL-F-BamHI is the BamHI restriction site, and the underlined part of the primer ACL-R-XbaI is the XbaI restriction site):
ACL-F-BamHI:5’-ATGCGGATCCATGTCGGCAAAGGTGCGTGGAATC-3’ACL-F-BamHI: 5'-ATGC GGATCC ATGTCGGCAAAGGTGCGTGGAATC-3'
ACL-R-XbaI:5’-TGACTCTAGACTACTGGCGCTGCTGGACGAGGAT-3’ACL-R-XbaI: 5'-TGAC TCTAGA CTACTGGCGCTGCTGGACGAGGAT-3'
引物方向均为5’至3’方向。The primers were all in the 5' to 3' direction.
以实施例2中构建的克隆载体pMD19T-RTACLc为模板,利用引物ACL-F-BamHI和ACL-R-XbaI扩增RT-ACL编码区序列,PCR片段经BamHI/XbaI双酶切,利用DNA回收试剂盒(购自北京舟鼎国,货号:NEP013-2),按照供应商建议步骤纯化酶切大片段;pJAM2质粒[Triccas,J.A.,T.Parish,W.J.Britton,and B.Giquel.FEMS Microbiol.Lett.1998,167,151-156]利用BamHI/XbaI双酶切后回收大片段。将RT-ACL cDNA酶切大片段pJAM2酶切大片段按5∶1的摩尔比混合,利用T4 DNA连接酶连接环化,转化E.coli DH5a化学感受态细胞,挑选Amp抗性转化子进行增菌培养、质粒提取(碧云天质粒小量提取试剂盒,货号:D0003)。重组质粒样品送至TaKaRa公司测序,经测序验证正确构建的重组质粒命名为pJAM-RL-ACLc。Using the cloning vector pMD19T-RTACLc constructed in Example 2 as a template, the primers ACL-F-BamHI and ACL-R-XbaI were used to amplify the sequence of the RT-ACL coding region, and the PCR fragment was double digested with BamHI/XbaI, and the DNA was recovered Kit (purchased from Beijing Zhoudingguo, article number: NEP013-2), according to the supplier's recommended steps to purify the large fragment; pJAM2 plasmid [Triccas, J.A., T.Parish, W.J.Britton, and B.Giquel. FEMS Microbiol. Lett.1998, 167, 151-156] using BamHI/XbaI double digestion to recover large fragments. Mix the RT-ACL cDNA digested large fragment pJAM2 digested large fragment at a molar ratio of 5:1, use T4 DNA ligase to ligate and circularize, transform E.coli DH5a chemically competent cells, and select Amp-resistant transformants for growth. Bacterial culture, plasmid extraction (Biyuntian Plasmid Small Extraction Kit, Cat. No.: D0003). The recombinant plasmid samples were sent to TaKaRa Company for sequencing, and the correctly constructed recombinant plasmid was named pJAM-RL-ACLc after sequencing verification.
利用电击转化方法,将pJAM-RL-ACLc质粒转化至浑浊红球菌(R.opacus)ATCC51881(购自ATCC:American Tissue Culture Colection)感受态细胞,挑取抗性转化子进行PCR鉴定,PCR鉴定阳性转化子命名为PD630/pJAM-RL-ACLc[Kalscheuer R,M.and A Steinbüchel.ApplMicrobiol Biotechnol1999,52,508-515.]。Transform the pJAM-RL-ACLc plasmid into competent cells of Rhodococcus opacus (R.opacus) ATCC51881 (purchased from ATCC: American Tissue Culture Colection) by electric shock transformation method, and pick the resistant transformants for PCR identification, and the PCR identification is positive The transformants were named PD630/pJAM-RL-ACLc [Kalscheuer R, M. and A Steinbüchel. Appl Microbiol Biotechnol 1999, 52, 508-515.].
将重组浑浊红球菌PD630/pJAM-RL-ACLc接种于含0.01g/l NH4Cl和10g/l葡萄糖酸钠的MSM培养基[Schlegel H G,H.Kaltwasser,and G.Gottschalk.Arch.Mikrobiol.1961,38,209-222.],28℃,200rpm,培养24h,每隔6h取样,留做油脂含量分析[JanMarcHorstRobenek,Alexander SteinbüchelAppl.Environ.Microbiol.2006,72(10),6743.]。结果发现,与对照菌株R.opacus PD630相比,重组浑浊红球菌R.opacus PD630/pJAM-RL-ACLc胞内油脂含量由30%增加到了74%。证明RL-ACL基因可促进浑浊红球菌油脂含量显著增加。Recombinant Rhodococcus turbide PD630/pJAM-RL-ACLc was inoculated in MSM medium containing 0.01g/l NH 4 Cl and 10g/l sodium gluconate [Schlegel H G, H.Kaltwasser, and G.Gottschalk.Arch.Mikrobiol. 1961, 38, 209-222.], 28°C, 200rpm, cultivated for 24 hours, took samples every 6 hours, and kept them for oil content analysis [Jan Marc Horst Robenek, Alexander Steinbüchel Appl. Environ. Microbiol. 2006, 72(10), 6743.]. It was found that, compared with the control strain R. opacus PD630, the intracellular lipid content of the recombinant Rhodococcus opacus R. opacus PD630/pJAM-RL-ACLc increased from 30% to 74%. It was proved that the RL-ACL gene can promote a significant increase in the lipid content of Rhodococcus opacus.
实施例7:Rt-ACL重组莱茵衣藻的构建Embodiment 7: Construction of Rt-ACL recombinant Chlamydomonas reinhardtii
根据rldp1的核苷酸序列设计以下引物(引物ACL-F-XbaI的下划线部分为XbaI酶切位点,引物ACL-R-NotI的下划线部分为NotI酶切位点):Design the following primers according to the nucleotide sequence of rldp1 (the underlined part of the primer ACL-F-XbaI is the XbaI restriction site, and the underlined part of the primer ACL-R-NotI is the NotI restriction site):
ACL-F-XbaI:5’-ATGCTCTAGAATGTCGGCAAAGGTGCGTGGAATC-3’ACL-F-XbaI: 5'-ATGC TCTAGA ATGTCGGCAAAGGTGCGTGGAATC-3'
ACL-R-NotI:5’-TGACGCGGCCGCCTACTGGCGCTGCTGGACGAGGAT-3’ACL-R-NotI: 5'-TGAC GCGGCCGCCTACTGGCGCTGCTGGACGAGGAT -3'
引物方向均为5’至3’方向。The primers were all in the 5' to 3' direction.
以实施例2中构建的克隆载体pMD19T-RTACLc为模板,利用引物ACL-F-XbaI和ACL-R-NotI扩增RT-ACL编码区序列,PCR片段经XbaI/NotI双酶切,连接入同样双酶切的pChlamy_1(购自Invitrogen,货号:A14258)载体(回收酶切大片断用于连接),转化E.coli DH5a化学感受态细胞,挑选Amp抗性转化子进行增菌培养、质粒提取(碧云天质粒小量提取试剂盒,货号:D0003)。重组质粒样品送至TaKaRa公司测序,经测序验证正确构建的重组质粒命名为pChlamy_1-RLACLc。利用ScaI将重组质粒pChlamy_1-RLDP1线性化,再利用DNA回收试剂盒(购自北京舟鼎国,货号:NEP013-2),按照供应商建议步骤(NEP013-2说明书)纯化PCR产物,-20℃保存备用。Using the cloning vector pMD19T-RTACLc constructed in Example 2 as a template, primers ACL-F-XbaI and ACL-R-NotI were used to amplify the sequence of the RT-ACL coding region, and the PCR fragment was double digested with XbaI/NotI and ligated into the same Double-digested pChlamy_1 (purchased from Invitrogen, article number: A14258) vector (recovering large fragments for ligation) was transformed into E.coli DH5a chemically competent cells, and Amp-resistant transformants were selected for enrichment culture and plasmid extraction ( Biyuntian plasmid mini-extraction kit, item number: D0003). The recombinant plasmid samples were sent to TaKaRa Company for sequencing, and the correctly constructed recombinant plasmid was named pChlamy_1-RLACLc after sequencing verification. Use ScaI to linearize the recombinant plasmid pChlamy_1-RLDP1, and then use the DNA recovery kit (purchased from Beijing Zhoudingguo, article number: NEP013-2) to purify the PCR product according to the supplier's recommended steps (NEP013-2 instructions), -20 °C Save for later.
莱茵衣藻(C.reinhardtii)ATCC-50049(购自ATCC:American TissueCulture Colection)利用GibcoR TAP培养基(购自Invitrogen,货号:A1379801)培养至OD750值为0.5,按照试剂盒说明书(货号:A14258)制备莱茵衣藻C.reinhardtii CC-849电击感受态细胞,取250μl感受态细胞,加入2μg前述线性化的pChlamy_1-RLACLc重组质粒,室温下温育5min,按照如下参数(电压600V,电容50μF,电阻无穷大),利用Bio-RadGene Pulser II进行电击转化。转化后立即加入5ml TAP-40mM蔗糖溶液(TAP购自Invitrogen,货号:A1379801,补加40mM蔗糖),于6孔培养板28℃,50μE m-2s-1条件下复苏24h,再2000rpm离心5min收集藻体,涂布于TAP-agar-Hygromycin平板(TAP购自Invitrogen,货号:A1379801,补加2%琼脂粉,100μg/ml潮霉素),28℃,50μE m-2s-1条件下培养5d,挑取潮霉素抗性转化子,利用ACL-F-XbaI和ACL-R-Not进行PCR鉴定,阳性克隆命名为CC-849/pChlamy_1-RLACLc。Chlamydomonas reinhardtii (C. reinhardtii) ATCC-50049 (purchased from ATCC: American Tissue Culture Colection) was cultured with GibcoR TAP medium (purchased from Invitrogen, product number: A1379801) until the OD750 value was 0.5, according to the kit instructions (product number: A14258) Prepare Chlamydomonas reinhardtii CC-849 electric shock competent cells, take 250 μl competent cells, add 2 μg of the aforementioned linearized pChlamy_1-RLACLc recombinant plasmid, incubate at room temperature for 5 min, according to the following parameters (voltage 600V, capacitance 50 μF, resistance Infinity), using Bio-RadGene Pulser II for electroporation transformation. Immediately after transformation, add 5ml TAP-40mM sucrose solution (TAP is purchased from Invitrogen, product number: A1379801, add 40mM sucrose), recover in 6-well culture plate at 28°C, 50μE m-2s-1 for 24h, then centrifuge at 2000rpm for 5min to collect Algae, spread on TAP-agar-Hygromycin plate (TAP purchased from Invitrogen, product number: A1379801, supplemented with 2% agar powder, 100 μg/ml hygromycin), cultured at 28°C, 50 μE m-2s-1 for 5 days , Pick hygromycin-resistant transformants, use ACL-F-XbaI and ACL-R-Not for PCR identification, and the positive clone is named CC-849/pChlamy_1-RLACLc.
重组莱茵衣藻CC-849/pChlamy_1-RLACLc接种TAP限氮培养基(缩写为TAP-N:Tris碱20mM,MgSO4·7H2O0.83mM,CaCl2·2H2O0.45mM,K2HPO41.65mM,KH2PO41.05mM,冰醋酸0.1%(V/V),痕量元素溶液1ml/l培养基,痕量元素溶液配方:Na2EDTA·2H2O5g/100ml,ZnSO4·7H2O2.2g/100ml,H3BO31.14g/100ml,MnCl2·4H2O0.5g/100ml,FeSO4·7H2O0.5g/100ml,CoCl2·6H2O0.16g/100ml,CuSO4·5H2O0.16g/100ml,(NH4)6Mo7O24·4H2O0.11g/100ml)28℃,持续光照70μE m-2s-1条件下培养4d,每隔24h取样,留做油脂含量分析和荧光观测[Moellering EricR.,Benning1Christoph,Eukaryotic Cell2010,9,97-106]。结果发现,与对照菌株莱茵衣藻CC-849相比,重组莱茵衣藻CC-849/pChlamy_1-RLACLc胞内油脂含量由18%增加到了39%。证明RL-ACL基因可促进莱茵衣藻油脂含量显著增加。Recombinant Chlamydomonas reinhardtii CC-849/pChlamy_1-RLACLc was inoculated with TAP nitrogen-limited medium (abbreviated as TAP-N: Tris base 20mM, MgSO4·7H2O0.83mM, CaCl2·2H2O0.45mM, K2HPO41.65mM, KH2PO41.05mM, glacial acetic acid 0.1% (V/V), trace element solution 1ml/l medium, trace element solution formula: Na2EDTA·2H2O5g/100ml, ZnSO4·7H2O2.2g/100ml, H3BO31.14g/100ml, MnCl2·4H2O0.5g/ 100ml, FeSO4 7H2O 0.5g/100ml, CoCl2 6H2O 0.16g/100ml, CuSO4 5H2O 0.16g/100ml, (NH4) 6Mo7O24 4H2O 0.11g/100ml) 28°C, continuous light 70μE m-2s-1 After culturing for 4 days, samples were taken every 24 hours for oil content analysis and fluorescence observation [Moellering EricR., Benning1Christoph, Eukaryotic Cell2010, 9, 97-106]. It was found that, compared with the control strain Chlamydomonas reinhardtii CC-849, the intracellular lipid content of the recombinant Chlamydomonas reinhardtii CC-849/pChlamy_1-RLACLc increased from 18% to 39%. It is proved that RL-ACL gene can promote the significant increase of oil content in Chlamydomonas reinhardtii.
应该理解,尽管参考其示例性的实施方案,已经对本发明进行具体地显示和描述,但是本领域的普通技术人员应该理解,在不背离由权利要求书所定义的本发明的精神和范围的条件下,可以在其中进行各种形式和细节的变化,可以进行各种实施方案的任意组合。It should be understood that while the invention has been particularly shown and described with reference to exemplary embodiments thereof, those skilled in the art will appreciate that, without departing from the spirit and scope of the invention as defined by the appended claims, Various changes in form and details can be made therein, and any combination of various embodiments can be made.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310067821.2A CN104031902A (en) | 2013-03-04 | 2013-03-04 | Oleaginous yeast ATP citrate lyase (ACL) and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310067821.2A CN104031902A (en) | 2013-03-04 | 2013-03-04 | Oleaginous yeast ATP citrate lyase (ACL) and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104031902A true CN104031902A (en) | 2014-09-10 |
Family
ID=51462900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310067821.2A Pending CN104031902A (en) | 2013-03-04 | 2013-03-04 | Oleaginous yeast ATP citrate lyase (ACL) and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104031902A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006138005A2 (en) * | 2005-05-10 | 2006-12-28 | Monsanto Technology, Llc | Genes and uses for plant improvement |
| CN101466259A (en) * | 2005-05-10 | 2009-06-24 | 孟山都技术有限公司 | Gene for plant improvement and use thereof |
-
2013
- 2013-03-04 CN CN201310067821.2A patent/CN104031902A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006138005A2 (en) * | 2005-05-10 | 2006-12-28 | Monsanto Technology, Llc | Genes and uses for plant improvement |
| CN101466259A (en) * | 2005-05-10 | 2009-06-24 | 孟山都技术有限公司 | Gene for plant improvement and use thereof |
Non-Patent Citations (2)
| Title |
|---|
| ZHIWEI ZHU,等: "Rhodosporidium toruloides NP11, whole genome shot gun sequencing project", 《GENBANK:ALAU01000000》 * |
| ZHIWEI ZHU等: "A multi-moic map of the lipid-producing yeast Rhodosporidium toruloides", 《NATURE COMMUNICATIONS》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2718442B1 (en) | Genetic manipulation and expression systems for pucciniomycotina and ustilaginomycotina subphyla | |
| CN109943515A (en) | A kind of recombinant bacteria producing carboxylesterase and its application | |
| Zhang et al. | irrE, an exogenous gene from Deinococcus radiodurans, improves the growth of and ethanol production by a Zymomonas mobilis strain under ethanol and acid stresses | |
| CN101812409B (en) | Recombinant yeast and preparation method thereof | |
| EP2970993B1 (en) | Polynucleotide sequences from rhodosporidium and rhodotor ula and use thereof | |
| CN104726477B (en) | A kind of fatty enzyme coding gene and its engineered strain | |
| CN104830880B (en) | A kind of alginate lyase SHA I genes and its expression vector | |
| CN107937296A (en) | One kind has acetic acid furfural vanillic aldehyde tolerance recombinant Saccharomyces cerevisiae and preparation method, application | |
| CN107937297A (en) | Mortifier stress tolerance saccharomyces cerevisiae more than one plant and preparation method, application | |
| CN111321127A (en) | A kind of cracking polysaccharide monooxygenase and preparation method | |
| CN111088177B (en) | Construction and application of heat-resistant yeast engineering bacteria for producing glycerol under high-temperature aerobic condition | |
| EP3830282A1 (en) | Increased alcohol production from yeast producing an increased amount of active crz1 protein | |
| CN104561082B (en) | One plant of yeast Candida jeffriesii that can utilize xylose expression system | |
| CN104031902A (en) | Oleaginous yeast ATP citrate lyase (ACL) and application thereof | |
| CN102952818B (en) | For improving construct and the method for fatty alcohol yield in cyanobacteria | |
| CN101157898A (en) | A Schizosaccharomyces pombe engineering bacterium with cellulase activity and its construction method | |
| CN113265343B (en) | Construction method and application of recombinant hansenula polymorpha | |
| CN104031896B (en) | A kind of oleaginous yeast fatty acid synthase and encoding gene thereof and application | |
| CN103965307B (en) | A kind of oleaginous yeast fat drips albumen and encoding gene thereof and application | |
| CN103965304B (en) | A kind of oleaginous yeast fat drips albumen and encoding gene thereof and application | |
| CN104031895B (en) | A kind of oleaginous yeast fatty acid synthase and encoding gene thereof and application | |
| CN101423815B (en) | Recombinant Clostridium acetobutylicum and its construction method and application | |
| CN116622784B (en) | Application of cannabidiolic acid synthase | |
| CN103421698A (en) | Construction and application of engineering strains with high temperature and high yield of xylitol | |
| WO2003085111A1 (en) | Novel promoters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140910 |
|
| RJ01 | Rejection of invention patent application after publication |